MPP Strikes Long-Acting Injectable Cabotegravir Deal For HIV PrEP

Prospective Sub-Licensees Have Until 4 September To Submit Expressions Of Interest

 
• By David Wallace
  
MPP Medicines Patent Pool Logo Hand Syringe
The MPP has secured a license for long-acting injectable cabotegravir • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business